Cargando…
Novel eIF4A1 inhibitors with anti‐tumor activity in lymphoma
BACKGROUND: Deregulated translation initiation is implicated extensively in cancer initiation and progression. It is actively pursued as a viable target that circumvents the dependency on oncogenic signaling, a significant factor in current strategies. Eukaryotic translation initiation factor (eIF)...
Autores principales: | Kayastha, Forum, Herrington, Noah B., Kapadia, Bandish, Roychowdhury, Anirban, Nanaji, Nahid, Kellogg, Glen E., Gartenhaus, Ronald B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9441068/ https://www.ncbi.nlm.nih.gov/pubmed/36058921 http://dx.doi.org/10.1186/s10020-022-00534-0 |
Ejemplares similares
-
PARK2 Regulates eIF4B-Driven Lymphomagenesis
por: Kapadia, Bandish B., et al.
Publicado: (2022) -
Fatty Acid Synthase induced S6Kinase facilitates USP11-eIF4B complex formation for sustained oncogenic translation in DLBCL
por: Kapadia, Bandish, et al.
Publicado: (2018) -
Role of hypoxia in Diffuse Large B-cell Lymphoma: Metabolic repression and selective translation of HK2 facilitates development of DLBCL
por: Bhalla, Kavita, et al.
Publicado: (2018) -
MNKs act as a regulatory switch for eIF4E1 and eIF4E3 driven mRNA translation in DLBCL
por: Landon, Ari L., et al.
Publicado: (2014) -
Author Correction: Role of hypoxia in Diffuse Large B-cell Lymphoma: Metabolic repression and selective translation of HK2 facilitates development of DLBCL
por: Bhalla, Kavita, et al.
Publicado: (2018)